Development of candidate drugs for the treatment of Alzheimer's disease. I. investigation of metal chelators as inhibitors of the beta-amyloid aggregation; II. Development of tacrine-ibuprofen hybrids

• Grant number: 10/20861-2
• Support Opportunities: Regular Research Grants
• Start date: April 01, 2011
• End date: March 31, 2013
• Field of knowledge: Health Sciences - Pharmacy
• Principal Investigator: Wanda Pereira Almeida
• Grantee: Wanda Pereira Almeida
• Host Institution: Instituto de Química (IQ). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil

Scientific publications

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

OLIVEIRA, F. L.; HUBER, P. C.; ALMEIDA, W. P.; SABINO, J. R.; APARICIO, R.. Tris[2-(1,3-thiazol-2-yl-kappa N)-1H-benzimidazole-kappa N-3]zinc(II) dinitrate ethanol hemisolvate monohydrate at 100 K. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, v. 69, n. 2, p. 119+, FEB 2013. (10/20861-2, 09/51602-5)

HUBER, PAULA C.; REIS, GABRIELLA P.; AMSTALDEN, MARIA C. K.; LANCELLOTTI, MARCELO; ALMEIDA, WANDA P.. Synthesis, spectroscopic characterizations and antimicrobial activity of copper and zinc complexes of levofloxacin, ciprofloxacin and 3-carboxy-4-quinolone. Polyhedron, v. 57, p. 14-19, JUL 2 2013. (11/21693-9, 10/20861-2)

OLIVEIRA, F. L.; HUBER, P. C.; ALMEIDA, W. P.; SABINO, J. R.; APARICIO, R.. Tris[2-(1,3-thiazol-2-yl-kappa N)-1H-benzimidazole-kappa N-3]zinc(II) dinitrate ethanol hemisolvate monohydrate at 100 K. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, v. 69, p. 13-pg., 2013-02-01. (10/20861-2, 09/51602-5)